These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25641469)

  • 41. Fiducial markers and spacers in prostate radiotherapy: current applications.
    Ng M; Brown E; Williams A; Chao M; Lawrentschuk N; Chee R
    BJU Int; 2014 Mar; 113 Suppl 2():13-20. PubMed ID: 24894851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. National survey of fiducial marker insertion for prostate image guided radiotherapy.
    Alexander SE; Kinsella J; McNair HA; Tree AC
    Radiography (Lond); 2018 Nov; 24(4):275-282. PubMed ID: 30292494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A review on the application of image fusion technology in prostate cancer radiotherapy based on gold fiducial biomarker].
    Zhao JC; Tian L
    Zhonghua Nan Ke Xue; 2023 Dec; 29(12):1038-1042. PubMed ID: 38639959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful implementation of image-guided radiation therapy quality assurance in the Trans Tasman Radiation Oncology Group 08.01 PROFIT Study.
    Middleton M; Frantzis J; Healy B; Jones M; Murry R; Kron T; Plank A; Catton C; Martin J
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1576-81. PubMed ID: 21074334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Localized prostatic cancer: treatment exclusive by radiotherapy guided by imagery, experiences in Luxembourg in 2005 and 2006].
    Untereiner M; Renard-Oldrini S; Mecellem H; Burie D; Lassen Y; Phy RR; Phy SJ; Phy LH
    Bull Soc Sci Med Grand Duche Luxemb; 2008; (4):559-64. PubMed ID: 19024375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study.
    Martin T; Baltas D; Kurek R; Röddiger S; Kontova M; Anagnostopoulos G; Dannenberg T; Buhleier T; Skazikis G; Tunn U; Zamboglou N
    Strahlenther Onkol; 2004 Apr; 180(4):225-32. PubMed ID: 15057433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fiducial markers in prostate cancer image-guided radiotherapy.
    Ghaffari H; Navaser M; Mofid B; Mahdavi SR; Mohammadi R; Tavakol A
    Med J Islam Repub Iran; 2019; 33():15. PubMed ID: 31086794
    [No Abstract]   [Full Text] [Related]  

  • 48. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose escalation in image-guided, intensity-modulated radiotherapy of carcinoma prostate: initial experience in India.
    Swamy K; Sathiya Narayanan VK; Basu S; Maiya V; Achari R; Deshpande S; Bhangle J; Gupta KK; Babu N; Pawar S; Atre A; Balachandra K; Koppiker CB
    J Cancer Res Ther; 2009; 5(4):277-83. PubMed ID: 20160362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of fiducial markers in image-guided radiotherapy for gastric cancer.
    Sia J; Glance S; Chandran S; Vaughan R; Hamilton C
    J Med Imaging Radiat Oncol; 2013 Oct; 57(5):626-8. PubMed ID: 24119280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity.
    Quon H; Cheung PC; Loblaw DA; Morton G; Pang G; Szumacher E; Danjoux C; Choo R; Thomas G; Kiss A; Mamedov A; Deabreu A
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):898-905. PubMed ID: 21237581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical experience with image-guided radiotherapy in an accelerated partial breast intensity-modulated radiotherapy protocol.
    Leonard CE; Tallhamer M; Johnson T; Hunter K; Howell K; Kercher J; Widener J; Kaske T; Paul D; Sedlacek S; Carter DL
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):528-34. PubMed ID: 19467799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postprostatectomy ultrasound-guided transrectal implantation of gold markers for external beam radiotherapy. Technique and complications rate.
    Langenhuijsen JF; Donker R; McColl GM; Kiemeney LA; Witjes JA; van Lin EN
    Strahlenther Onkol; 2013 Jun; 189(6):476-81. PubMed ID: 23604186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy.
    Park WG; Yan BM; Schellenberg D; Kim J; Chang DT; Koong A; Patalano C; Van Dam J
    Gastrointest Endosc; 2010 Mar; 71(3):513-8. PubMed ID: 20189509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transrectal implantation and stability of gold markers in prostate bed for salvage radiotherapy of macroscopic recurrences.
    Shakir SI; Udrescu C; Enachescu C; Rouviere O; Arion S; Caraivan I; Chapet O
    Phys Med; 2016 Nov; 32(11):1422-1427. PubMed ID: 27810195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of kV cone-beam ct performance for prostate IGRT: a comparison of automatic grey-value alignment to implanted fiducial-marker alignment.
    Shi W; Li JG; Zlotecki RA; Yeung A; Newlin H; Palta J; Liu C; Chvetsov AV; Olivier K
    Am J Clin Oncol; 2011 Feb; 34(1):16-21. PubMed ID: 21189455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05).
    Lawton CA; DeSilvio M; Lee WR; Gomella L; Grignon D; Gillin M; Morton G; Pisansky T; Sandler H
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):39-47. PubMed ID: 17084551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiparametric prostate MRI-based intensity-modulated radiation therapy guided by prostatic calcifications.
    Kao J; Karwowski P; Pettit J; Barney AK; Atalla C
    Br J Radiol; 2020 Dec; 93(1116):20200571. PubMed ID: 32846099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.